Concord Healthcare Group Statistics

Total Valuation

Concord Healthcare Group has a market cap or net worth of HKD 11.09 billion. The enterprise value is 14.10 billion.

Market Cap	11.09B
Enterprise Value	14.10B

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Concord Healthcare Group has 716.34 million shares outstanding. The number of shares has increased by 6.68% in one year.

Current Share Class	n/a
Shares Outstanding	716.34M
Shares Change (YoY)	+6.68%
Shares Change (QoQ)	+9.52%
Owned by Insiders (%)	4.95%
Owned by Institutions (%)	0.93%
Float	114.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.22
PB Ratio	5.41
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-36.39
EV / Sales	27.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-69.40

Financial Position

The company has a current ratio of 0.53, with a Debt / Equity ratio of 1.34.

Current Ratio	0.53
Quick Ratio	0.38
Debt / Equity	1.34
Debt / EBITDA	n/a
Debt / FCF	-15.26
Interest Coverage	-3.24

Financial Efficiency

Return on equity (ROE) is -19.54% and return on invested capital (ROIC) is -4.30%.

Return on Equity (ROE)	-19.54%
Return on Assets (ROA)	-3.85%
Return on Capital (ROIC)	-4.30%
Revenue Per Employee	734,668
Profits Per Employee	-560,869
Employee Count	733
Asset Turnover	0.08
Inventory Turnover	13.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	17.57
200-Day Moving Average	27.08
Relative Strength Index (RSI)	43.90
Average Volume (20 Days)	3,130,570

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Concord Healthcare Group had revenue of HKD 507.66 million and -387.56 million in losses. Loss per share was -0.56.

Revenue	507.66M
Gross Profit	-69.43M
Operating Income	-371.64M
Pretax Income	-449.92M
Net Income	-387.56M
EBITDA	-249.14M
EBIT	-371.64M
Loss Per Share	-0.56

Full Income Statement

Balance Sheet

The company has 356.89 million in cash and 3.10 billion in debt, giving a net cash position of -2.74 billion or -3.83 per share.

Cash & Cash Equivalents	356.89M
Total Debt	3.10B
Net Cash	-2.74B
Net Cash Per Share	-3.83
Equity (Book Value)	2.32B
Book Value Per Share	2.86
Working Capital	-654.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 165.20 million and capital expenditures -368.41 million, giving a free cash flow of -203.22 million.

Operating Cash Flow	165.20M
Capital Expenditures	-368.41M
Free Cash Flow	-203.22M
FCF Per Share	-0.28

Full Cash Flow Statement

Margins

Gross margin is -13.68%, with operating and profit margins of -73.21% and -76.34%.

Gross Margin	-13.68%
Operating Margin	-73.21%
Pretax Margin	-88.63%
Profit Margin	-76.34%
EBITDA Margin	-49.08%
EBIT Margin	-73.21%
FCF Margin	-40.03%

Dividends & Yields

Concord Healthcare Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.68%
Shareholder Yield	-6.68%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Concord Healthcare Group has an Altman Z-Score of 1.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.74
Piotroski F-Score	n/a